Addex Moves R&D Operations to Geneva’s Campus Biotech

Addex Moves R&D Operations to Geneva’s Campus Biotech Addex TherapeuticsPosted on: 07 Dec 15 Geneva, Switzerland, December 7, 2015 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development announced today that it has moved its R&D operations to the Campus Biotech, a new life sciences center of excellence located at the former Merck Serono site in Geneva. “We are delighted to welcome Addex to our center of excellence in life science. As a leader in allosteric modulator drug discovery which is ideally suited to neuroscience, Addex is perfectly aligned with our mission to build a center of excellence in life science and in particular neuroscience,” commented Dr. Benoît Dubuis, Director Campus Biotech and Development Director Wyss Center. “Joining the center of excellence in life…


Link to Full Article: Addex Moves R&D Operations to Geneva’s Campus Biotech